Publikasjoner - Rusmidler

• Melby K, Gråwe RW, Aamo TO, Salvesen Ø, Spigset O. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial. Drug Alcohol Depend 2019; 197: 95-101.
https://www.ncbi.nlm.nih.gov/pubmed/?term=30784955
• Gundersen PO, Spigset O, Josefsson M. Screening, confirmation and quantification of synthetic cannabinoids in urine by UHPLC-QTOF-MS. Drug Test Anal 2019; 11: 51-67.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29996011
• Brede WR, Krabseth HM, Michelsen LS, Aarset H, Jamt JP, Slørdal L. A wolf in sheep’s clothing, J Anal Toxicol 2019.
https://www.ncbi.nlm.nih.gov/pubmed/?term=30295817
• Hegstad S, Havnen H, Helland A, Spigset O, Frost J. Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometry. J Chromatography B 2018; 1077-8: 7-12.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29413579
• Andreassen TN, Havnen H, Spigset O, Falch BMH, Skråstad R. High throughput UHPC-MSMS method for the analysis of phosphatidylethanol (PEth) 16:0/18:1, a specific biomarker for alcohol consumption, in whole blood. J Anal Toxicol 2018; 42: 33-41.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28977407
• Hegstad S, Helland A, Hagemann C, Spigset O. EtG/EtS in serum by UHPLC-MS-MS in suspected sexual assault cases. J Anal Toxicol, 2017; 41: 618-22.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28453638
• Edvardsen HM, Tverborgvik T, Frost J, Rogde S, Morild I, Waal H, Clausen T, Slørdal L, Vindenes V. Differences in combinations and concentrations of drugs of abuse in fatal intoxication and driving under the influence cases. Forensic Sci Int 2017; 281: 127-33.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29128652
• Helland A, Brede WR, Michelsen LS, Gundersen POM, Aarset H, Skjølås JE, Slørdal L. Two hospitalizations and one death after exposure to ortho-fluorofentanyl. J Anal Toxicol 2017; 41: 708-709.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28985336
• Strand MC, Mørland J, Slørdal L, Riedel B, Innerdal C, Aamo T, Mathisrud G, Vindenes V. Conversion factors for assessment of driving impairment after exposure to multiple benzodiazepines/z-hypnotics or opioids. Forensic Sci Int 2017; 281: 29-36.
https://www.ncbi.nlm.nih.gov/pubmed/?term=29101905
• Westin AA, Frost J, Brede WR, Gundersen PO, Einvik S, Aarset H, Slørdal L.
Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA. J Anal Toxicol 2016; 40: 86-7.
https://www.ncbi.nlm.nih.gov/pubmed/26353925  
• Helland A, Lydersen S, Lervåg LE, Jenssen GD, Mørland J, Slørdal L. Driving simulator sickness: Impact on driving performance, influence of blood alcohol concentration, and effect of repeated simulator exposures. Accid Anal Prev 2016; 94:180-7.
https://www.ncbi.nlm.nih.gov/pubmed/27322638  
• Krabseth HM, Tuv SS, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Øiestad EL, Vindenes V. Nye psykoaktive stoffer. Tidsskr Nor Legeforen 2016; 136: 714-7.
http://tidsskriftet.no/2016/05/klinisk-oversikt/nye-psykoaktive-stoffer  
• Aakerøy R, Skråstad RB, Helland A, Hilberg H, Aamo T, Dyrkorn R, Spigset O. Nye markører for påvisning av alkoholbruk. Tidsskr Nor Legeforen 2016; 136: 1643-7.
http://tidsskriftet.no/2016/10/klinisk-oversikt/nye-markorer-pavisning-av-alkoholbruk  
• Strand MC, Innerdal C, Mathisrud G, Mørland J, Riedel B, Slørdal L, Aamo TO, Vindenes V. Revisjon av faste grenser for rusmidler i trafikken. Tidsskr Nor Legeforen 2016; 136: 1619-20.
http://tidsskriftet.no/2016/10/kommentar-og-debatt/revisjon-av-faste-grenser-rusmidler-i-trafikken